Tag: Prescription Drugs
Nivolumab Promising for Treatment of Advanced Cutaneous SCC
Robust antitumor activity and good tolerability observed in phase 2 study of nivolumab for first-line treatment of advanced cutaneous squamous cell carcinoma
Effectiveness of Antipsychotics Dips for Women After Age 45 Years
Findings compared with both younger women and similarly aged men
Ruxolitinib Cream Results in Greater Repigmentation in Vitiligo
More patients receiving ruxolitinib have decrease of at least 75 percent from baseline in facial Vitiligo Area Scoring Index
FDA Panel Votes for Removal of Drug Meant to Prevent Preterm Births
Phosphodiesterase-5 Inhibitors Not Tied to Alzheimer Disease Risk
No evidence seen for reduced risk for Alzheimer disease and related dementia across four separate analytic approaches
FDA, Company Square Off in Hearing Over Drug Meant to Prevent Preterm Births
FDA officials want to withdraw the drug because of a lack of evidence of its efficacy and because of side effects
Major Trial of Monkeypox Treatment TPOXX to Launch in Africa
TPOXX is currently only approved to treat smallpox but has been used to treat infections during global monkeypox outbreak
Thiazolidinedione Monotherapy for T2DM Tied to Lower Dementia Risk
Sulfonylurea monotherapy linked to increased risk for all-cause dementia compared with metformin monotherapy
Cefepime/Enmetazobactam Noninferior for Complicated UTI
Cefepime/enmetazobactam is noninferior and superior to piperacillin/tazobactam for clinical cure and microbial eradication
Lenabasum Studied for Refractory Cutaneous Dermatomyositis
Results of phase 2 study suggest clinical benefit and favorable safety profile, warranting further study of lenabasum for DM
